New Pancreatic Cancer Drug Nearly Doubles Survival. Here’s What Patients Should Know

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...
Pancreatic Cancer Action Network

First RAS Inhibitor Extends Survival in Previously Treated Metastatic Pancreatic Adenocarcinoma: What You Need to Know

Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...
Regulatory Affairs Professionals Society

FDA drafts guidance on using next-generation sequencing to assess gene therapy safety

The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
The Aviationist on MSN

SNC's ATHENA-S ISR Jets Are Now Operational with the U.S. Army

Sierra Nevada Corporation announced that two Contractor-Owned Contractor-Operated ATHENA-S jets finished testing and are now operational in support of the U.S. Army's Aerial-ISR mission. Sierra Nevada ...
Dronelife

Counter-Drone Systems Begin to Shape Civil Airspace Rules

The FAA and Department of Defense sign a counter-drone agreement following Texas airspace disruptions, setting new rules for cUAS deployment.
Rasmussen Reports

Daily Presidential Tracking Poll

The Rasmussen Reports daily Presidential Tracking Poll for Thursday shows that 44% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-four (54%) disapprove. The latest figures ...